Stilla Technologies
Stilla Technologies is a Paris-based european biotechnology company.
About Stilla Technologies
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.
Company Facts
- Headquarters
- Villejuif
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00051_00100
- Funding Stage
- m_and_a
- Total Funding
- $101,706,716
- Last Funding Type
- series_c
- Last Funding Date
- 2024-02-22
- Website
- stillatechnologies.com
Industries & Categories
Biotechnology, Consumer Research, Genetics, Test and Measurement
Social Links
Canonical: https://fsome.com/organization/stilla-technologies-27713 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.